Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Teva, Novartis and Aurobindo Pharma Companies Investing Heavily in the Pharmaceutical Ingredients Market
  • USA - English


News provided by

Mordor Intelligence

30 Sep, 2016, 14:00 IST

Share this article

Share toX

Share this article

Share toX

HYDERABAD, India, September 30, 2016 /PRNewswire/ --

Mordor Intelligence announces the publication of their research report on the active pharmaceutical ingredients market. The report titled, "Global Active Pharmaceutical Ingredients (API) Market Growth, Trends & Forecasts," discusses the current landscape and outlook of the market.

The global active pharmaceutical ingredients market was valued at USD 154 billion in 2015 and is projected to reach USD 225 billion by 2021, at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2016 to 2021.

The report is an amalgamation of the current market scenario, its prospects and forces driving and restraining the market growth. Impact of pharmaceutical industry on the active pharmaceutical ingredients market and increasing adoption of biologicals and biosimilars are fuelling the market. Drug price control policies across various countries and fierce competition between the API manufacturers are turning out to be restraints for this market.

Browse Related Reports Here

The market for active pharmaceutical ingredients can be segmented as:

  • By Business Mode
    • Captive API
    • Merchant API
  • By Type of Synthesis
    • Synthetic
    • Biotech
  • By Customer Base
    • Generic
    • Branded
  • By Application
    • Cardiology
    • Pulmonology
    • Oncology
    • Ophthalmology
    • Neurology
    • Orthopedics
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • Middle East & Africa
    • South America

North America is currently the largest active pharmaceutical ingredients market globally. Asia-Pacific region is expected to emerge as fastest growing region due to low operation costs and high investments in medical research. Furthermore, the high cost of trained labor and energy are the most important factors that enforced European market to move their base to develop countries such as India and China.

The leading companies that dominate this market are TAPI, Novartis, Aurobindo, Dr.Reddy's, among others

About Mordor Intelligence: 

Mordor Intelligence is a global market research and consulting firm. Our focus is to provide research insights to facilitate business success. Our research expertise covers niche segments under Agriculture, Healthcare, ICT, Chemicals, Manufacturing, Logistics, Electronics and Automotive, among others. We believe in data, and we provide solutions through it. Optimum solutions and goal-oriented strategies define our endeavors and make us the preferred choice for clients.

For information regarding permissions and sales, please contact: [email protected]

Media Contact:
Madan Gopal
AVP - Marketing & Strategy
Email: [email protected]
Direct Line: +1 617-765-2493

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.